Genetic analysis of the E2 transactivation domain dimerization interface from bovine papillomavirus type 1

Virology

Volumn 439, Issue 2, 2013, Pages 132-139

  Gagnon, David ^a   Sénéchal, Hélène ^a   D'Abramo, Claudia M ^a   Alvarez, Jennifer ^a   McBride, Alison A ^b   Archambault, Jacques ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

BPV1; Dimer; Dimerization; DNA replication; E2; High throughput assay; Protein interface; Redox; Transactivation; Transactivation domain

Indexed keywords

ARGININE; ASPARTIC ACID; CYSTEINE; E2 PROTEIN; MUTANT PROTEIN; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN;

AMINO ACID SUBSTITUTION; ARTICLE; BOVINE PAPILLOMAVIRUS TYPE 1; CONTROLLED STUDY; DIMERIZATION; DNA REPLICATION; E2 GENE; EPISOME; FEMALE; GENETIC ANALYSIS; GENETIC CODE; HUMAN; HUMAN CELL; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TRANSACTIVATION; TRANSCRIPTION INITIATION; VIRUS GENE; VIRUS GENOME;

AMINO ACID SUBSTITUTION; BOVINE PAPILLOMAVIRUS 1; DNA MUTATIONAL ANALYSIS; DNA, VIRAL; DNA-BINDING PROTEINS; HUMANS; MUTANT PROTEINS; PROTEIN MULTIMERIZATION; VIRAL PROTEINS; VIRUS REPLICATION;

BOVINE PAPILLOMAVIRUS TYPE 1; BOVINE PARVOVIRUS;

EID: 84875805189     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2013.02.012     Document Type: Article

References (44)

1. Abbate E.A., Berger J.M., Botchan M.R. The X-ray structure of the papillomavirus helicase in complex with its molecular matchmaker E2. Genes Dev. 2004, 18(16):1981-1996.
2. Abbate E.A., Voitenleitner C., Botchan M.R. Structure of the papillomavirus DNA-tethering complex E2:Brd4 and a peptide that ablates HPV chromosomal association. Mol. Cell 2006, 24(6):877-889.
3. Abroi A., Ilves I., Kivi S., Ustav M. Analysis of chromatin attachment and partitioning functions of bovine papillomavirus type 1 E2 protein. J. Virol. 2004, 78(4):2100-2113.
4. Abroi A., Kurg R., Ustav M. Transcriptional and replicational activation functions in the bovine papillomavirus type 1 E2 protein are encoded by different structural determinants. J. Virol. 1996, 70(9):6169-6179.
5. Antson A.A., Burns J.E., Moroz O.V., Scott D.J., Sanders C.M., Bronstein I.B., Dodson G.G., Wilson K.S., Maitland N.J. Structure of the intact transactivation domain of the human papillomavirus E2 protein. Nature 2000, 403(6771):805-809.
6. Baxter M.K., McPhillips M.G., Ozato K., McBride A.A. The mitotic chromosome binding activity of the papillomavirus E2 protein correlates with interaction with the cellular chromosomal protein, Brd4. J. Virol. 2005, 79(8):4806-4818.
7. Benson J.D., Howley P.M. Amino-terminal domains of the bovine papillomavirus type 1 E1 and E2 proteins participate in complex formation. J. Virol. 1995, 69(7):4364-4372.
8. Bernard H.U. Gene expression of genital human papillomaviruses and considerations on potential antiviral approaches. Antiviral Ther. 2002, 7(4):219-237.
9. Blachon S., Demeret C. The regulatory E2 proteins of human genital papillomaviruses are pro-apoptotic. Biochimie 2003, 85(8):813-819.
10. Breiding D.E., Grossel M.J., Androphy E.J. Genetic analysis of the bovine papillomavirus E2 transcriptional activation domain. Virology 1996, 221(1):34-43.
11. Brokaw J.L., Blanco M., McBride A.A. Amino acids critical for the functions of the bovine papillomavirus type 1 E2 transactivator. J. Virol. 1996, 70(1):23-29.
12. Clower R.V., Hu Y., Melendy T. Papillomavirus E2 protein interacts with and stimulates human topoisomerase I. Virology 2006, 348(1):13-18.
13. Donaldson M.M., Mackintosh L.J., Bodily J.M., Dornan E.S., Laimins L.A., Morgan I.M. An interaction between human papillomavirus 16 E2 and TopBP1 is required for optimum viral DNA replication and episomal genome establishment. J. Virol. 2012, 86(23):12806-12815.
14. Doorbar J. The papillomavirus life cycle. J. Clin. Virol. 2005, 32(Suppl 1):S7-S15.
15. Ferguson M.K., Botchan M.R. Genetic analysis of the activation domain of bovine papillomavirus protein E2: its role in transcription and replication. J. Virol. 1996, 70(7):4193-4199.
16. Fradet-Turcotte A., Morin G., Lehoux M., Bullock P.A., Archambault J. Development of quantitative and high-throughput assays of polyomavirus and papillomavirus DNA replication. Virology 2010, 399(1):65-76.
17. Gagnon D., Joubert S., Senechal H., Fradet-Turcotte A., Torre S., Archambault J. Proteasomal degradation of the papillomavirus E2 protein is inhibited by overexpression of bromodomain-containing protein 4. J. Virol. 2009, 83(9):4127-4139.
18. Grossel M.J., Sverdrup F., Breiding D.E., Androphy E.J. Transcriptional activation function is not required for stimulation of DNA replication by bovine papillomavirus type 1 E2. J. Virol. 1996, 70(10):7264-7269.
19. Harris S.F., Botchan M.R. Crystal structure of the human papillomavirus type 18 E2 activation domain. Science 1999, 284(5420):1673-1677.
20. Hebner C.M., Laimins L.A. Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity. Rev. Med. Virol. 2006, 16(2):83-97.
21. Hegde R.S. The papillomavirus E2 proteins: structure, function, and biology. Annu. Rev. Biophys. Biomol. Struct. 2002, 31:343-360.
22. Hernandez-Ramon E.E., Burns J.E., Zhang W., Walker H.F., Allen S., Antson A.A., Maitland N.J. Dimerization of the human papillomavirus type 16 E2 N terminus results in DNA looping within the upstream regulatory region. J. Virol. 2008, 82(10):4853-4861.
23. Fields Virology 2001, vol. 2:2231-2264. Lippincott Raven, Philadelphia, PA, D.M. Knipe. fourth ed.
24. Kurg R., Parik J., Juronen E., Sedman T., Abroi A., Liiv I., Langel U., Ustav M. Effect of bovine papillomavirus E2 protein-specific monoclonal antibodies on papillomavirus DNA replication. J. Virol. 1999, 73(6):4670-4677.
25. Kurg R., Tekkel H., Abroi A., Ustav M. Characterization of the functional activities of the bovine papillomavirus type 1 E2 protein single-chain heterodimers. J. Virol. 2006, 80(22):11218-11225.
26. Kurg R., Uusen P., Sepp T., Sepp M., Abroi A., Ustav M. Bovine papillomavirus type 1 E2 protein heterodimer is functional in papillomavirus DNA replication in vivo. Virology 2009, 386(2):353-359.
27. Kurg R., Uusen P., Vosa L., Ustav M. Human papillomavirus E2 protein with single activation domain initiates HPV18 genome replication, but is not sufficient for long-term maintenance of virus genome. Virology 2010, 408(2):159-166.
28. Li R., Botchan M.R. The acidic transcriptional activation domains of VP16 and p53 bind the cellular replication protein A and stimulate in vitro BPV-1 DNA replication. Cell 1993, 73(6):1207-1221.
29. Longworth M.S., Laimins L.A. Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol. Mol. Biol. Rev. 2004, 68(2):362-372.
30. McPhillips M.G., Oliveira J.G., Spindler J.E., Mitra R., McBride A.A. Brd4 is required for e2-mediated transcriptional activation but not genome partitioning of all papillomaviruses. J. Virol. 2006, 80(19):9530-9543.
31. Oliveira J.G., Colf L.A., McBride A.A. Variations in the association of papillomavirus E2 proteins with mitotic chromosomes. Proc. Nat. Acad. Sci. U.S.A. 2006, 103(4):1047-1052.
32. Penrose K.J., McBride A.A. Proteasome-mediated degradation of the papillomavirus E2-TA protein is regulated by phosphorylation and can modulate viral genome copy number. J. Virol. 2000, 74(13):6031-6038.
33. Piirsoo M., Ustav E., Mandel T., Stenlund A., Ustav M. Cis and trans requirements for stable episomal maintenance of the BPV-1 replicator. EMBO J. 1996, 15(1):1-11.
34. Sakai H., Yasugi T., Benson J.D., Dowhanick J.J., Howley P.M. Targeted mutagenesis of the human papillomavirus type 16 E2 transactivation domain reveals separable transcriptional activation and DNA replication functions. J. Virol. 1996, 70(3):1602-1611.
35. Sanders C.M., Sizov D., Seavers P.R., Ortiz-Lombardia M., Antson A.A. Transcription activator structure reveals redox control of a replication initiation reaction. Nucleic Acids Res. 2007, 35(10):3504-3515.
36. Schweiger M.R., You J., Howley P.M. Bromodomain protein 4 mediates the papillomavirus E2 transcriptional activation function. J. Virol. 2006, 80(9):4276-4285.
37. Senechal H., Poirier G.G., Coulombe B., Laimins L.A., Archambault J. Amino acid substitutions that specifically impair the transcriptional activity of papillomavirus E2 affect binding to the long isoform of Brd4. Virology 2007, 358(1):10-17.
38. Ustav M., Stenlund A. Transient replication of BPV-1 requires two viral polypeptides encoded by the E1 and E2 open reading frames. EMBO J. 1991, 10(2):449-457.
39. Wang Y., Coulombe R., Cameron D.R., Thauvette L., Massariol M.J., Amon L.M., Fink D., Titolo S., Welchner E., Yoakim C., Archambault J., White P.W. Crystal structure of the E2 transactivation domain of human papillomavirus type 11 bound to a protein interaction inhibitor. J. Biol. Chem. 2004, 279(8):6976-6985.
40. Wu S.Y., Chiang C.M. The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation. J. Biol. Chem. 2007, 282(18):13141-13145.
41. Wu S.Y., Lee A.Y., Hou S.Y., Kemper J.K., Erdjument-Bromage H., Tempst P., Chiang C.M. Brd4 links chromatin targeting to HPV transcriptional silencing. Genes Dev. 2006, 20(17):2383-2396.
42. You J., Croyle J.L., Nishimura A., Ozato K., Howley P.M. Interaction of the bovine papillomavirus E2 protein with Brd4 tethers the viral DNA to host mitotic chromosomes. Cell 2004, 117(3):349-360.
43. You J., Schweiger M.R., Howley P.M. Inhibition of E2 binding to Brd4 enhances viral genome loss and phenotypic reversion of bovine papillomavirus-transformed cells. J. Virol. 2005, 79(23):14956-14961.
44. zur Hausen H., de Villier E.M. Human papillomaviruses. Annual Rev. Microbiol. 1994, 48:427-447.